EntrepreneurialCheck
Stephen Van Dien estimated net worth profile

Stephen Van Dien net worth

Stephen Van Dien Net Worth 2026 (Estimated) · CTO at Persephone Biosciences · YC W18
est. wealth $60.0M

Quick answer

Stephen Van Dien's estimated net worth is $60.0M (range $42.0M – $90.0M) as of 2026. Stephen Van Dien is CTO at Persephone Biosciences. Persephone Biosciences valuation.

Stephen Van Dien is CTO at Persephone Biosciences (YC W18). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameStephen Van Dien
RoleCTO
CompanyPersephone Biosciences
YC batchW18
Est. company val$150.0M
Assumed ownership40%
Est. paper wealth / net worth$60.0M
$42.0M – $90.0M
  • Company status: Active
  • Education: Bachelor's degree in Molecular and Cell Biology from UC Berkeley
  • Region: United States of America
  • Industries: Healthcare, Therapeutics
  • Team size: 6
  • Website: http://persephonebiosciences.com/

Who is Stephen Van Dien?

Stephen Van Dien is a co-founder of Persephone Biosciences, involved in developing microbiome-based therapies.

Highlights:

  • University of California, Berkeley
  • Stanford University
  • Participated in Y Combinator W18

About Persephone Biosciences

Persephone Biome develops live biotherapeutic products to modulate the metabolism of gut microbes, for applications in disease prevention and cure. We take a unique engineering approach using systems and synthetic biology to understand the complexities of the microbiome.

FAQ: Stephen Van Dien net worth and Persephone Biosciences valuation

What is Stephen Van Dien's net worth?

Stephen Van Dien's estimated net worth is $60.0M (range $42.0M – $90.0M) as of 2026. Stephen Van Dien is CTO at Persephone Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Persephone Biosciences valuation?

Persephone Biosciences's estimated valuation on Entrepreneurial Check is $150.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Stephen Van Dien's role?

Stephen Van Dien is CTO at Persephone Biosciences, a Y Combinator-backed startup (batch W18).